Signaling via epidermal growth factor and its receptor is an essential oncogenic pathway in HNSCC and oral squamous cell carcinoma (OSCC), and this signaling pathway enhanced AKT activation and upregulated C/EBPβ expression in OSCC [24]. The gene discussed is CEBPB; the disease is head and neck squamous cell carcinoma.